Carolyn Chapman

Carolyn Riley Chapman, PhD MS, joined the MRCT Center in October 2023. She is a Member of the Faculty of the Department of Medicine at Harvard Medical School and Lead Investigator in the Division of Global Health Equity (DGHE), Department of Medicine, Brigham and Women’s Hospital. Carolyn’s work involves collaboration with diverse stakeholders to identify and address challenges in the research and development of precision medicine, including cell and gene therapies.

Prior to joining the MRCT Center, Carolyn was Faculty in the Center for Human Genetics and Genomics at NYU Grossman School of Medicine with a primary appointment as Research Assistant Professor in the Department of Population Health (Division of Medical Ethics). At NYU, she also served as Director of Research Ethics Education in the Translational Research Education and Careers (TREC) Unit of the Clinical & Translational Science Institute (CTSI) and as the organizer of and lecturer in the NYU component of the WCG International Fellows Program. In the past, she has also worked as an Associate/Lecturer and as Interim Associate Director for the Columbia Bioethics program; as a business strategy management consultant in the biopharmaceuticals industry at L.E.K. Consulting; at a start-up biopharmaceutical company, Aton Pharma; and as a freelance science/medical writer.

Carolyn graduated summa cum laude from Dartmouth College with a BA in Biology. She has a PhD in Genetics from Harvard University and an MS in Bioethics from Columbia University. She completed a postdoctoral fellowship in medical ethics at NYU Grossman School of Medicine and a Graduate Certificate in Survey Research at UConn’s School of Public Policy.